Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_assertion type Assertion NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_head.
- NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_assertion description "[The GSTM1 null genotype, however, was significantly overrepresented among larger (T3 and T4) primary tumors (OR 7.61, 0.95 CI 1.05-333) and with the occurrence of axillary lymph node metastases (OR 1.62, 0.95 CI 0.98-2.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_provenance.
- NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_assertion evidence source_evidence_literature NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_provenance.
- NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_assertion SIO_000772 11810042 NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_provenance.
- NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_assertion wasDerivedFrom befree-2016 NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_provenance.
- NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_assertion wasGeneratedBy ECO_0000203 NP343209.RAa-PmgI8TjTFD7ZXw2E7kvi4FHixYo5cPExDEoC0CFjE130_provenance.